Therapeutic Areas: Cardiology/Vascular Diseases | Hematology

Thrombosis Clinical Trials


A listing of Thrombosis medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

Alabama

Muscle Shoals : Dr Terence Hart

Patients are needed to participate in a clinical research study to evaluate Venous Thromboembolism, Deep Vein Thrombosis or Pulmonary Embolism

Arizona

Tucson : Pima Vascular, Tucson Medical Center

Patients are needed to participate in a clinical research study evaluating EkoSonic Endovascular System for the treatment of Deep Venous Thrombosis or Post-thrombotic Syndrome

Arkansas

Little Rock : Baptist Medical Center

A clinical study for patients with HeartMate II Pump Thrombosis

California

La Jolla : University of California, San Diego

A clinical study for patients with HeartMate II Pump Thrombosis

La Jolla :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Los Angeles :

A clinical research study of Rivaroxaban (Xarelto, BAY59-7939) and Standard of care for the treatment of Venous Thrombosis

Los Angeles : UCLA Medical Center

Patients are needed to participate in a clinical research study evaluating EkoSonic Endovascular System for the treatment of Deep Venous Thrombosis or Post-thrombotic Syndrome

Sacramento : Sutter Memorial

A clinical study for patients with HeartMate II Pump Thrombosis

San Diego : Sharp Memorial Hospital

A clinical study for patients with HeartMate II Pump Thrombosis

Colorado

Aurora : University of Colorado

A clinical study for patients with HeartMate II Pump Thrombosis

Connecticut

New Haven : Yale-New haven Hospital

Patients are needed to participate in a clinical research study evaluating EkoSonic Endovascular System for the treatment of Deep Venous Thrombosis or Post-thrombotic Syndrome

Delaware

Newark : Christiana Hospital

Patients are needed to participate in a clinical research study evaluating EkoSonic Endovascular System for the treatment of Deep Venous Thrombosis or Post-thrombotic Syndrome

Florida

Boca Raton : Boca Raton Regional Hospital

Patients are needed to participate in a clinical research study of Aspirin and Ticagrelor to evaluate Saphenous Vein Graft Disease

Gainesville : Shands Hospital at University of Florida

A clinical study for patients with HeartMate II Pump Thrombosis

Tampa : Tampa General Hospital

Patients are needed to participate in a clinical research study evaluating EkoSonic Endovascular System for the treatment of Deep Venous Thrombosis or Post-thrombotic Syndrome

Tampa : Florida Hospital at Tampa

Patients are needed to participate in a clinical research study evaluating EkoSonic Endovascular System for the treatment of Deep Venous Thrombosis or Post-thrombotic Syndrome

Georgia

Atlanta :

A Phase 2 clinical study for patients with Venous Thromboembolism

Atlanta : Medical Center of Central Georgia

Patients are needed to participate in a clinical research study evaluating EkoSonic Endovascular System for the treatment of Deep Venous Thrombosis or Post-thrombotic Syndrome

Columbus :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Illinois

Chicago : University of Chicago

A clinical study for patients with HeartMate II Pump Thrombosis

Chicago : Northwestern Medical Faculty Foundation, Div of Hematology/Oncology

A clinical study for patients with Unresectable Hepatocellular Carcinoma With Portal Vein Thrombosis

Indiana

Indianapolis : St. Vincent Hospital

Patients are needed to participate in a clinical research study evaluating EkoSonic Endovascular System for the treatment of Deep Venous Thrombosis or Post-thrombotic Syndrome

Kentucky

Louisville : University of Louisville Research Foundation

Patients are needed to participate in a clinical research study evaluating EkoSonic Endovascular System for the treatment of Deep Venous Thrombosis or Post-thrombotic Syndrome

Maine

Portland : Maine Medical Center

Patients are needed to participate in a clinical research study evaluating EkoSonic Endovascular System for the treatment of Deep Venous Thrombosis or Post-thrombotic Syndrome

Rockport :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Michigan

Ann Arbor : University of Michigan Medical Center

Patients are needed to participate in a clinical research study evaluating EkoSonic Endovascular System for the treatment of Deep Venous Thrombosis or Post-thrombotic Syndrome

Detroit :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Detroit :

A clinical research study of Rivaroxaban (Xarelto, BAY59-7939) and Standard of care for the treatment of Venous Thrombosis

Minnesota

Minneapolis : University of Minnesota Medical Center

A clinical study for patients with HeartMate II Pump Thrombosis

Rochester : Mayo Clinic, St. Mary's

A clinical study for patients with HeartMate II Pump Thrombosis

Montana

Butte :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

New Jersey

Hackensack : Hackensack Medical Center

Patients are needed to participate in a clinical research study evaluating EkoSonic Endovascular System for the treatment of Deep Venous Thrombosis or Post-thrombotic Syndrome

Livingston : Saint Barnabas Medical Center

Patients are needed to participate in a clinical research study evaluating EkoSonic Endovascular System for the treatment of Deep Venous Thrombosis or Post-thrombotic Syndrome

Teaneck : Holy Name Medical Center

Patients are needed to participate in a clinical research study evaluating EkoSonic Endovascular System for the treatment of Deep Venous Thrombosis or Post-thrombotic Syndrome

New York

New Hyde Park :

A clinical research study of Rivaroxaban (Xarelto, BAY59-7939) and Standard of care for the treatment of Venous Thrombosis

New York : Mount Sinai School of Medicine

A clinical study for patients with Unresectable Hepatocellular Carcinoma With Portal Vein Thrombosis

New York : Icahn School of Medicine at Mount Sinai

A clinical trial seeking patients for a research study for the treatment of Coronary Artery Disease

New York : Icahn School of Medicine at Mount Sinai

A clinical trial seeking patients for a research study for the treatment of Type-2 Diabetes Mellitus or Coronary Artery Disease

North Carolina

Chapel Hill : University of North Carolina

A clinical study for patients with HeartMate II Pump Thrombosis

Raleigh :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

North Dakota

Bismarck : Legacy Pharma Research

Prevention of venous thromboembolism (VTE) in cancer patients at high risk for VTE and who are undergoing chemotherapy

Ohio

Canton : Aultman Hospital

Patients are needed to participate in a clinical research study evaluating EkoSonic Endovascular System for the treatment of Deep Venous Thrombosis or Post-thrombotic Syndrome

Cincinnati : The Christ Hospital

A clinical study for patients with HeartMate II Pump Thrombosis

Columbus : Ohio State University

A clinical study for patients with HeartMate II Pump Thrombosis

Columbus :

A clinical research study of Rivaroxaban (Xarelto, BAY59-7939) and Standard of care for the treatment of Venous Thrombosis

Lancaster : Fairfield Medical Center

Patients are needed to participate in a clinical research study evaluating EkoSonic Endovascular System for the treatment of Deep Venous Thrombosis or Post-thrombotic Syndrome

Oklahoma

Oklahoma City : The University of Oklahoma Health Sciences Center

A clinical trial seeking patients for a research study for the treatment of Deep Venous Thrombosis

Oregon

Portland : Oregon Health & Science University

Patients are needed to participate in a clinical research study evaluating EkoSonic Endovascular System for the treatment of Deep Venous Thrombosis or Post-thrombotic Syndrome

Pennsylvania

Philadelphia : Thomas Jefferson University Hospital

A clinical study for patients with HeartMate II Pump Thrombosis

Pittsburgh : Allegheny General Hospital

A clinical study for patients with HeartMate II Pump Thrombosis

Tennessee

Nashville : Vanderbilt University Medical Center

A clinical study for patients with HeartMate II Pump Thrombosis

Texas

Dallas : DFW Vascular Group/ Methodist Dallas Medical Ctr

Patients are needed to participate in a clinical research study evaluating EkoSonic Endovascular System for the treatment of Deep Venous Thrombosis or Post-thrombotic Syndrome

Houston : Memorial Hermann/UT Texas

A clinical study for patients with HeartMate II Pump Thrombosis

Houston :

A clinical research study of Rivaroxaban (Xarelto, BAY59-7939) and Standard of care for the treatment of Venous Thrombosis

Virginia

Alexandria : Inova Alexandria Hospital

Patients are needed to participate in a clinical research study evaluating EkoSonic Endovascular System for the treatment of Deep Venous Thrombosis or Post-thrombotic Syndrome

Falls Church : Inova Fairfax Hospital

A clinical study for patients with HeartMate II Pump Thrombosis

Norfolk : Sentara Norfolk General Hospital

Patients are needed to participate in a clinical research study evaluating EkoSonic Endovascular System for the treatment of Deep Venous Thrombosis or Post-thrombotic Syndrome

Washington

Seattle :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Spokane :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Tacoma :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Australia

Melbourne :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

South Brisbane :

A clinical research study of Rivaroxaban (Xarelto, BAY59-7939) and Standard of care for the treatment of Venous Thrombosis

Austria

Graz :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Graz :

A clinical research study of Rivaroxaban (Xarelto, BAY59-7939) and Standard of care for the treatment of Venous Thrombosis

Innsbruck :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Innsbruck :

A clinical research study of Rivaroxaban (Xarelto, BAY59-7939) and Standard of care for the treatment of Venous Thrombosis

Wien :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Belgium

Aalst :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Brussels : Cliniques Universitaires Saint-Luc

A clinical study for patients with Unresectable Hepatocellular Carcinoma With Portal Vein Thrombosis

Bruxelles - Brussel :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Bruxelles - Brussel :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Hasselt :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Leuven :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Canada

Halifax :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Hamilton : Juravinski Hospital Updated

A clinical trial seeking patients for a research study for the treatment of Symptomatic Superficial Vein Thrombosis

Hamilton : McMaster Hospital Updated

A clinical trial seeking patients for a research study for the treatment of Symptomatic Superficial Vein Thrombosis

Hamilton : Hamilton General Hospital Updated

A clinical trial seeking patients for a research study for the treatment of Symptomatic Superficial Vein Thrombosis

Montreal :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Montreal :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Montreal :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Ottawa :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Ottawa :

A clinical research study of Rivaroxaban (Xarelto, BAY59-7939) and Standard of care for the treatment of Venous Thrombosis

Saint John :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Toronto : St. Michael's Hospital

A clinical trial seeking patients for a research study of Atorvastatin and Placebo

China

Changchun :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Changsha :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Hong Kong : Prince of Wales Hospital

A Phase 0 clinical study for patients with Atrial Fibrillation or Stroke

Czech Republic

Kladno :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Liberec :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Litomysl :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Ostrava :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Ostrava :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Praha 1 :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Praha 2 :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Praha 5 :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Denmark

Aarhus : Consultant Anne-Mette Hvas

A Phase 4 clinical study for patients with Fetal Growth Retardation

Copenhagen :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Glostrup :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Hellerup :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Herning :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

København NV :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Svendborg :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

France

Arras :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Besancon :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Brest Cedex :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Castelnau Le Lez :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Clermont Ferrand :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Colombes Cedex :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Dijon :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Grenoble :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Le Mans :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Limoges Cedex :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Many locations :

A clinical study for patients with Venous Thrombosis

Marseille : Paoli-Calmettes Institute

A clinical study for patients with Unresectable Hepatocellular Carcinoma With Portal Vein Thrombosis

Montpellier Cedex :

A clinical research study of Rivaroxaban (Xarelto, BAY59-7939) and Standard of care for the treatment of Venous Thrombosis

Nice :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Paris :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Paris Cedex 15 :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Saint Etienne :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Strasbourg Cedex :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Toulouse :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Vernon :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Georgia

Tblisi : Acad. N. Bokhua Centre of Vascular and Heart Diseases

Patients are needed to participate in a clinical research study of Bemiparin sodium and enoxaparin sodium to evaluate Deep Vein Thrombosis

Germany

Bad Krozingen : University Heart Center; Department of Cardiology and Angiology II

Patients are needed to participate in a clinical research study of Dabigatran etexilate and Phenprocoumon to evaluate (Atrial Fibrillation), (Atrial Flutter), or Thrombosis of Left Atrial Appendage

Baesweiler : Chriurgische Praxisklinik

A clinical research study of Rivaroxaban and Fondaparinux for the treatment of Superficial Vein Thrombosis

Berlin :

A clinical research study of Rivaroxaban (Xarelto, BAY59-7939) and Standard of care for the treatment of Venous Thrombosis

Berlin : MVZ Ramdohr, Praxis für Cardiovaskulär- u. Ultraschalldiagnostik

A clinical research study of Rivaroxaban and Fondaparinux for the treatment of Superficial Vein Thrombosis

Berlin : Franziskus-Krankenhaus Berlin

A clinical research study of Rivaroxaban and Fondaparinux for the treatment of Superficial Vein Thrombosis

Berlin : Praxis für Chirurgie & Gefäßmedizin

A clinical research study of Rivaroxaban and Fondaparinux for the treatment of Superficial Vein Thrombosis

Berlin : Vivantes Clinical Center Am Urban; General Internal Medicine and conservative intensive care

Patients are needed to participate in a clinical research study of Dabigatran etexilate and Phenprocoumon to evaluate (Atrial Fibrillation), (Atrial Flutter), or Thrombosis of Left Atrial Appendage

Dresden :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Dresden :

A clinical research study of Rivaroxaban (Xarelto, BAY59-7939) and Standard of care for the treatment of Venous Thrombosis

Dresden : Universitätsklinikum Dresden

A clinical research study of Rivaroxaban and Fondaparinux for the treatment of Superficial Vein Thrombosis

Dresden : Krankenhaus Dresden-Friedrichstadt

A clinical research study of Rivaroxaban and Fondaparinux for the treatment of Superficial Vein Thrombosis

Dresden : University Heart Center; Department of Invasive Electrophysiology

Patients are needed to participate in a clinical research study of Dabigatran etexilate and Phenprocoumon to evaluate (Atrial Fibrillation), (Atrial Flutter), or Thrombosis of Left Atrial Appendage

Erfurt :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Eschwege : Gemeinschaftspraxis Eggeling und Winter

A clinical research study of Rivaroxaban and Fondaparinux for the treatment of Superficial Vein Thrombosis

Freiburg : Hautarztpraxis

A clinical research study of Rivaroxaban and Fondaparinux for the treatment of Superficial Vein Thrombosis

Görlitz : Oberlausitz-Gefäßpraxis

A clinical research study of Rivaroxaban and Fondaparinux for the treatment of Superficial Vein Thrombosis

Hamburg : Asklepios Westklinikum Hamburg

A clinical research study of Rivaroxaban and Fondaparinux for the treatment of Superficial Vein Thrombosis

Hamburg : University Heart Center; Department of Cardiology, Electrophysiology

Patients are needed to participate in a clinical research study of Dabigatran etexilate and Phenprocoumon to evaluate (Atrial Fibrillation), (Atrial Flutter), or Thrombosis of Left Atrial Appendage

Heidelberg : Universitätsklinikum Heidelberg

A clinical research study of Rivaroxaban and Fondaparinux for the treatment of Superficial Vein Thrombosis

Hoppegarten : Internistische Praxisgemeinschaft

A clinical research study of Rivaroxaban and Fondaparinux for the treatment of Superficial Vein Thrombosis

Karlsbach : Akademie für Gefäßkrankheiten e.V.

A clinical research study of Rivaroxaban and Fondaparinux for the treatment of Superficial Vein Thrombosis

Köln : Praxis für Allgemeinmedizin un dPhlebologie

A clinical research study of Rivaroxaban and Fondaparinux for the treatment of Superficial Vein Thrombosis

Köln : University Heart Center; Department of Cardiology

Patients are needed to participate in a clinical research study of Dabigatran etexilate and Phenprocoumon to evaluate (Atrial Fibrillation), (Atrial Flutter), or Thrombosis of Left Atrial Appendage

Leipzig : Universitätsklinikum Leipzig AöR Innere Medizin - Angiologische Ambulanz

A clinical research study of Rivaroxaban and Fondaparinux for the treatment of Superficial Vein Thrombosis

Lübeck :

A clinical research study of Rivaroxaban (Xarelto, BAY59-7939) and Standard of care for the treatment of Venous Thrombosis

Lübeck : Universitätsklinikum Schleswig-Holstein, Campus Lübeck

A clinical research study of Rivaroxaban and Fondaparinux for the treatment of Superficial Vein Thrombosis

Magdeburg : Praxis Dr. Franke

A clinical research study of Rivaroxaban and Fondaparinux for the treatment of Superficial Vein Thrombosis

Mainz :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Mainz : University Hospital Mainz, II. Medical Clinic, Dept. of Electrophysiology

Patients are needed to participate in a clinical research study of Dabigatran etexilate and Phenprocoumon to evaluate (Atrial Fibrillation), (Atrial Flutter), or Thrombosis of Left Atrial Appendage

Mühldorf am Inn : Kardiologie Mühldorf am Inn

A clinical research study of Rivaroxaban and Fondaparinux for the treatment of Superficial Vein Thrombosis

München :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

München : Gemeinschaftspraxis Mietaschk, Bilderling, Kaiser, Tato

A clinical research study of Rivaroxaban and Fondaparinux for the treatment of Superficial Vein Thrombosis

Münster : University Medical Center

Patients are needed to participate in a clinical research study of Dabigatran etexilate and Phenprocoumon to evaluate (Atrial Fibrillation), (Atrial Flutter), or Thrombosis of Left Atrial Appendage

Rostock : Praxis Dr. Kähler

A clinical research study of Rivaroxaban and Fondaparinux for the treatment of Superficial Vein Thrombosis

Rottach-Egern : Praxis für Gefäßmedizin am Tegernsee

A clinical research study of Rivaroxaban and Fondaparinux for the treatment of Superficial Vein Thrombosis

Wiesbaden : Venezentrum Wiesbaden

A clinical research study of Rivaroxaban and Fondaparinux for the treatment of Superficial Vein Thrombosis

Witten :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Israel

Afula :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Haifa :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Haifa :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Holon :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Jerusalem :

A clinical research study of Rivaroxaban (Xarelto, BAY59-7939) and Standard of care for the treatment of Venous Thrombosis

Kfar Saba :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Nahariya :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Petach Tikva :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Safed :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Italy

Bari :

A clinical research study of Rivaroxaban (Xarelto, BAY59-7939) and Standard of care for the treatment of Venous Thrombosis

Bergamo : UO Radiologia, Ospedali Riuniti di Bergamo

A clinical study for patients with Unresectable Hepatocellular Carcinoma With Portal Vein Thrombosis

Bergamo : Cardiovascular Department Ospedali Riuniti di Bergamo

A clinical trial seeking patients for a research study for the treatment of Coronary Artery Disease

Genova :

A clinical research study of Rivaroxaban (Xarelto, BAY59-7939) and Standard of care for the treatment of Venous Thrombosis

Milano : Fondazione Istituto Nazionale Tumori di Milano

A clinical study for patients with Unresectable Hepatocellular Carcinoma With Portal Vein Thrombosis

Milano :

A clinical research study of Rivaroxaban (Xarelto, BAY59-7939) and Standard of care for the treatment of Venous Thrombosis

Torino :

A clinical research study of Rivaroxaban (Xarelto, BAY59-7939) and Standard of care for the treatment of Venous Thrombosis

Japan

Chubu :

A Phase 3 clinical study for patients with Portal Vein Thrombosis

Hokkaido :

A Phase 3 clinical study for patients with Portal Vein Thrombosis

Kanto :

A Phase 3 clinical study for patients with Portal Vein Thrombosis

Kyushu :

A Phase 3 clinical study for patients with Portal Vein Thrombosis

Osaka :

A Phase 3 clinical study for patients with Portal Vein Thrombosis

Kenya

Many Locations :

A clinical study for patients with Venous Thromboembolism (VTE)

Korea, Republic of

Busan :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Daegu :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Donggu, :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Many Locations :

A clinical study for patients with Venous Thromboembolism (VTE)

Seoul :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Seoul :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Seoul :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Netherlands

Alkmaar :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Amsterdam : Academic Medical Center

A clinical research study for the treatment of Deep Venous Thrombosis or Pulmonary Embolism

Amsterdam : VU medical center

A clinical research study for the treatment of Deep Venous Thrombosis or Pulmonary Embolism

Amsterdam : OLVG

A clinical research study for the treatment of Deep Venous Thrombosis or Pulmonary Embolism

Amsterdam :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Amsterdam :

A clinical research study of Rivaroxaban (Xarelto, BAY59-7939) and Standard of care for the treatment of Venous Thrombosis

Amsterdam :

A clinical research study of Rivaroxaban (Xarelto, BAY59-7939) and Standard of care for the treatment of Venous Thrombosis

Apeldoorn : Gelre Ziekenhuizen

A clinical research study for the treatment of Deep Venous Thrombosis or Pulmonary Embolism

Assen : Wilhelmina Ziekenhuis

A clinical research study for the treatment of Deep Venous Thrombosis or Pulmonary Embolism

Assen :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Breda : Amphia ziekenhuis

A clinical research study for the treatment of Deep Venous Thrombosis or Pulmonary Embolism

Delft : Reinier de Graaf Groep

A clinical research study for the treatment of Deep Venous Thrombosis or Pulmonary Embolism

Den Haag : HAGA ziekenhuis

A clinical research study for the treatment of Deep Venous Thrombosis or Pulmonary Embolism

Den Haag : Bronovo ziekenhuis

A clinical research study for the treatment of Deep Venous Thrombosis or Pulmonary Embolism

Deventer : Deventer Ziekenhuis

A clinical research study for the treatment of Deep Venous Thrombosis or Pulmonary Embolism

Dordrecht :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Groningen : UMCG

A clinical research study for the treatment of Deep Venous Thrombosis or Pulmonary Embolism

Groningen :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Heerlen : Atrium MC

A clinical research study for the treatment of Deep Venous Thrombosis or Pulmonary Embolism

Hoofddorp :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Maastricht :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Nijmegen : St. Radboud UMC

A clinical research study for the treatment of Deep Venous Thrombosis or Pulmonary Embolism

's-Hertogenbosch : Jeroen Bosch Ziekenhuis

A clinical research study for the treatment of Deep Venous Thrombosis or Pulmonary Embolism

Sittard :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Utrecht : UMCU

A clinical research study for the treatment of Deep Venous Thrombosis or Pulmonary Embolism

Zwolle :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

New Zealand

Auckland :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Palmerston North :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Wellington :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Norway

Fredrikstad :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Oslo :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Singapore

Many Locations :

A clinical study for patients with Venous Thromboembolism (VTE)

South Africa

Johannesburg :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Pretoria :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Worcester :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Spain

Barcelona : Hospital Clínic Barcelona. IDIBAPS. CIBEREHD. Liver Unit

A clinical study for patients with Unresectable Hepatocellular Carcinoma With Portal Vein Thrombosis

Girona :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

L'Hospitalet de Llobregat :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Madrid : Hospital Universitario Puerta de Hierro, Gastroenterology & Hepatology Dept

A clinical study for patients with Unresectable Hepatocellular Carcinoma With Portal Vein Thrombosis

Madrid :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

San Sebastián de los Reyes :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Torrevieja :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Valencia : Hospital Universitari i Politecnic la Fe

A clinical study for patients with Unresectable Hepatocellular Carcinoma With Portal Vein Thrombosis

Sweden

Göteborg :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Kristianstad :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Switzerland

Bern :

A clinical research study of Rivaroxaban (Xarelto, BAY59-7939) and Standard of care for the treatment of Venous Thrombosis

Genève :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Zürich :

A clinical research study of Rivaroxaban (Xarelto, BAY59-7939) and Standard of care for the treatment of Venous Thrombosis

Taiwan

New Taipei City :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Tunisia

Tunis : Hospital Charle Nicolle

A clinical research study of Enoxaparin for the treatment of Deep Vein Thrombosis, Enoxaparin or Anticoagulants

United Kingdom

Birmingham : University Hospitals Birmingham NHS Foundation Trust

A clinical study for patients with Unresectable Hepatocellular Carcinoma With Portal Vein Thrombosis

Liverpool : Royal Liverpool & Broadgreen University Hospital NHS Trust

Patients are needed to participate in a clinical research study evaluating Venepuncture for the treatment of Atrial Fibrillation, Pulmonary Embolism or Deep Vein Thrombosis

London : Royal Free London NHS Foundation Trust

A clinical study for patients with Unresectable Hepatocellular Carcinoma With Portal Vein Thrombosis

Newcastle Upon Tyne :

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Southampton : Drug Safety Research Unit

A clinical study for patients with Atrial Fibrillation, Deep Vein Thrombosis or Pulmonary Embolism